CG001419

N/A

Report date: 2026/02/09 20:01:27
NME

Base Information

Drug NameCG001419
Drug Alias NameCG-001419
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionTropomyosin-related kinase degraders
TargetsTropomyosin-related kinase
Therapy Area/IndicationsSolid tumoursPainNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesCullgen Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursPain
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A